Alpha Tau Medical LTD Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
SCHEDULE 13D: Oramed Pharmaceuticals Acquires Significant Stake and Strategic Influence in Alpha Tau Medical with $36.9 Million Investment
Oramed Pharmaceuticals Inc. and its subsidiary Oramed Ltd. have acquired a 19.99% beneficial ownership in Alpha Tau Medical Ltd. through a $36.9 million share purchase and entered into a strategic investor relations and public relations services agreement.